Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combining camouflage with psychotherapy improves quality of life for vitiligo patients.

Sex and sex hormones can affect brain inflammation in Parkinson's disease, with male mice being more affected and female mice showing a protective effect.

BMI is not enough for assessing obesity in women; use more personalized tools.

Altered lipid pathways in diabetic women may cause premature greying.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

Different types of RNAs are found in varying amounts in patients with Polycystic Ovary Syndrome, suggesting they could be important in the disease's development and potentially used as disease markers.

Fibroblast-derived growth factors and exosomes can significantly improve skin aging.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Endocrine disruptors may cause early hair loss.

PCOD increases weight but keeps BMI normal in young women.

Ethosomes are a promising way to deliver drugs through the skin.

Women with PCOS have higher renin and d-dimer levels, especially if they have COVID-19.

The mFG score is effective for diagnosing hirsutism.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Low testosterone may increase COVID-19 severity in men.

Humans can accurately guess age from faces, with women being slightly better at it, and age perception is linked to evolutionary factors.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

The mesenchymal stem cell secretome may effectively treat various diseases as an alternative to traditional stem cell therapies.

Androgens and other hormones affect hair growth and skin conditions like acne.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Female pattern hair loss affects 32.3% of women, increasing with age and showing no racial differences.

Acne treatment, including isotretinoin, improves quality of life and does not worsen depression.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.